Medical Sciences Divisional Office
University of Oxford
Level 3, John Radcliffe Hospital
Oxford OX3 9DU
Head of Medical Sciences Division
The Head of Division is responsible for maintaining and further developing the international reputation of Medical Sciences in both research and teaching. He provides vision and leadership across all aspects of the Division's activities including divisional research strategy, educational policy and standards, the recruitment and retention of outstanding academics, relationships with external funding agencies, interactions with local NHS Foundation Trusts, fundraising, improving diversity and equality, and the use of resources. He works closely with the heads of the 16 departments within the Division and the other University academic divisions to foster strong interdisciplinary links across the spectrum of academic activity and with the colleges to help maintain excellence in teaching for undergraduate and graduate courses.
The Head of Division is a member of University Council and its major committees, which are responsible for determining overall university strategy.
Prior to being appointed as the Head of the Medical Sciences Division, Professor Screaton was Dean of the Faculty of Medicine, Imperial College.
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ogbe A. et al, (2022), JCI Insight, 7
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
Spencer AJ. et al, (2022), eBioMedicine, 77, 103902 - 103902
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Wei J. et al, (2022), Nature Medicine
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15